NVIDIA CFO 10b5-1 sales reported; 2,828,122 shares direct post-trade
Rhea-AI Filing Summary
NVIDIA (NVDA) reported insider transactions by EVP & Chief Financial Officer Colette Kress. On 11/03/2025, she executed multiple open‑market sales pursuant to a Rule 10b5‑1 trading plan adopted on March 4, 2025. Reported tranches include 14,830 shares sold at a weighted average price of $207.9239, plus additional sales such as 4,280 shares at $207.0334 and 4,011 shares at $208.9187. Following these transactions, beneficial ownership was listed as 2,828,122 shares direct, and indirect holdings included 123,060 shares by trust and 752,934 shares by a limited liability company, with other family and grantor retained annuity trust positions disclosed. Weighted average price ranges for the tranches span $206.425 to $211.185.
Positive
- None.
Negative
- None.
Insights
Routine 10b5‑1 insider sales; neutral signal
The filing lists multiple open‑market sales by NVIDIA’s CFO on 11/03/2025 under a pre‑set Rule 10b5‑1 plan adopted on March 4, 2025. Tranches show weighted average prices, including $207.0334, $207.9239, and $208.9187, with additional sales reported within stated ranges.
Post‑transaction, the filing shows 2,828,122 shares direct and indirect positions such as 123,060 by trust and 752,934 by a limited liability company. These are administrative ownership updates; pricing ranges of $206.425–$211.185 are provided for transparency.
As a routine 10b5‑1 program sale, this does not by itself indicate a change in business outlook. Actual impact depends on the pre‑established plan terms disclosed.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common | 4,280 | $207.0334 | $886K |
| Sale | Common | 14,830 | $207.9239 | $3.08M |
| Sale | Common | 4,011 | $208.9187 | $838K |
| Sale | Common | 2,297 | $209.9018 | $482K |
| Sale | Common | 2,222 | $210.8573 | $469K |
| Sale | Common | 1,508 | $207.0374 | $312K |
| Sale | Common | 5,402 | $207.9283 | $1.12M |
| Sale | Common | 1,475 | $208.92 | $308K |
| Sale | Common | 854 | $209.9028 | $179K |
| Sale | Common | 761 | $210.8431 | $160K |
| Sale | Common | 1,514 | $207.0295 | $313K |
| Sale | Common | 5,360 | $207.9333 | $1.11M |
| Sale | Common | 1,521 | $208.9188 | $318K |
| Sale | Common | 873 | $209.9023 | $183K |
| Sale | Common | 732 | $210.8336 | $154K |
| holding | Common | -- | -- | -- |
| holding | Common | -- | -- | -- |
| holding | Common | -- | -- | -- |
| holding | Common | -- | -- | -- |
Footnotes (1)
- The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2025. Represents weighted average sales price. The shares were sold at prices ranging from $206.425 to $207.420. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the "SEC"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Represents weighted average sales price. The shares were sold at prices ranging from $207.425 to $208.410. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Represents weighted average sales price. The shares were sold at prices ranging from $208.425 to $209.395. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Represents weighted average sales price. The shares were sold at prices ranging from $209.425 to $210.415. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Represents weighted average sales price. The shares were sold at prices ranging from $210.425 to $211.185. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
FAQ
What did NVIDIA (NVDA) disclose in this Form 4?
What price ranges did the NVDA trades cover?
What indirect NVDA holdings were reported after the transactions?
Was the trading under a pre‑arranged plan?